Lipids, Lipoproteins, and Peroxisome Proliferator Activated Receptor-δ

American Journal of Cardiology

Volumn 100, Issue 11 SUPPL. 1, 2007, Pages

  Sprecher, Dennis L ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; LIPID; LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; TRIACYLGLYCEROL;

ARTICLE; ENERGY YIELD; EXERCISE; FATTY ACID OXIDATION; HUMAN; IN VITRO STUDY; MUSCLE TISSUE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; UPREGULATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; FATTY ACIDS; HUMANS; LIPID METABOLISM; LIPOPROTEINS; MUSCLE, SKELETAL; OXIDATION-REDUCTION; PPAR DELTA; THIAZOLES; UP-REGULATION;

EID: 36448944298     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.08.009     Document Type: Article

References (34)

1. Willson T.M., Brown P.J., Sternbach D.D., and Henke B.R. The PPARs: from orphan receptors to drug discovery. J Med Chem 43 (2000) 527-550
2. Berger J., and Moller D.E. The mechanisms of action of PPARs. Annu Rev Med 53 (2002) 409-435
3. Wahli W., Braissant O., and Desvergne B. Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more. Chem Biol 2 (1995) 261-266
4. Picard F., Kurtev M., Chung N., Topark-Ngarm A., Senawong T., Machado de Oliveira R., Leid M., McBurney M.W., and Guarente L. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ. Nature 429 (2004) 771-776
5. Fabris R., Nisoli E., Lombardi A.M., Tonello C., Serra R., Granzotto M., Cusin I., Rohner-Jeanrenaud F., Federspil G., Carruba M.O., and Vettor R. Preferential channeling of energy fuels toward fat rather than muscle during high free fatty acid availability in rats. Diabetes 50 (2001) 601-608
6. Gilde A.J., and Van Bilsen M. Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle. Acta Physiol Scand 178 (2003) 425-434
7. Kliewer S.A., Xu H.E., Lambert M.H., and Willson T.M. Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog Horm Res 56 (2001) 239-263
8. Muoio D.M., MacLean P.S., Lang D.B., Li S., Houmard J.A., Way J.M., Winegar D.A., Corton J.C., Dohm G.L., and Kraus W.E. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) α knock-out mice: evidence for compensatory regulation by PPAR δ. J Biol Chem 277 (2002) 26089-26097
9. Lee C.H., Olson P., and Evans R.M. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144 (2003) 2201-2207
10. Luquet S., Lopez-Soriano J., Holst D., Frederich A., Melki J., Rassoulzadegan M., and Grimaldi P.A. Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J 17 (2003) 2299-2301
11. Wang Y.-X., Zhang C.-L., Yu R.T., Cho H.K., Nelson M.C., Bayusga-Ocampo C.R., Ham J., Kang H., and Evans R.M. Regulation of muscle fiber type and running endurance by PPARδ. PLoS Biol 2 (2004) e294
12. Booth F.W., and Thomason D.B. Molecular and cellular adaptation of muscle in response to exercise: perspectives of various models. Physiol Rev 71 (1991) 541-585
13. Berchtold M.W., Brinkmeier H., and Muntener M. Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. Physiol Rev 80 (2000) 1215-1265
14. Tanaka T., Yamamoto J., Iwasaki S., Asaba H., Hamura H., Ikeda Y., Watanabe M., Magoori K., Ioka R.X., Tachibana K., et al. Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A 100 (2003) 15924-15929
15. Wang Y.-X., Lee C.H., Trep S., Yu R.T., Ham J., Kang H., and Evans R.M. Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity. Cell 113 (2003) 159-170
16. Baar K., Wende A.R., Jones T.E., Marison M., Nolte L.A., Chen M., Kelly D.P., and Holloszy O. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J 16 (2002) 1879-1886
17. Holloszy J.O. Biochemical adaptations in muscle: effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem 242 (1967) 2278-2782
18. Holst D., Luquet S., Nogueira V., Kristiansen K., Leverve X., and Grimaldi P.A. Nutritional regulation and role of peroxisome proliferator-activated receptor δ in fatty acid catabolism in skeletal muscle. Biochim Biophys Acta 1633 (2003) 43-50
19. Allen D.L., Harrison B.C., Maass A., Bell M.L., Byrnes W.C., and Leinwand L.A. Cardiac and skeletal muscle adaptations to voluntary wheel running in the mouse. J Appl Physiol 90 (2001) 1900-1908
20. Oliver Jr. W.R., Shenk J.L., Smith M.R., Russell C.S., Plunker K.D., Bodkin N.L., Lewis M.C., Winegar D.A., Sznaidman M.L., Lambert M.H., et al. A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport. Proc Natl Acad Sci U S A 98 (2001) 5306-5311
21. Wallace J.M., Schwarz M., Coward P., Houze J., Sawyer J.K., Kelley K.L., Chai A., and Rudell L.L. Effects of peroxisome proliferator-activated receptor α/δ agonists on HDL-cholesterol in vervet monkeys. J Lipid Res 46 (2005) 1009-1016
22. Tikkanen H.O., Hamalainen E., and Harkonen M. Significance of skeletal muscle properties on fitness, long-term physical training and serum lipids. Atherosclerosis 142 (1999) 367-378
23. Jarvis J.C., Mokrusch T., Kwende M.M., Sutherland H., and Salmon S. Fast-to-slow transformation in stimulated rat muscle. Muscle Nerve 19 (1996) 1469-1475
24. Pette D. Training effects on the contractile apparatus. Acta Physiol Scand 162 (1998) 367-376
25. Hood D.A. Invited review: contractile activity-induced mitochondrial biogenesis in skeletal muscle. J Appl Physiol 90 (2001) 1137-1157
26. Lopez-Soriano J., Chiellini C., Maffei M., Grimaldi P.A., and Argiles J.M. Roles of skeletal muscle and peroxisome proliferator-activated receptors in the development and treatment of obesity. Endocr Rev 27 (2006) 318-329
27. Kelley D.E., and Goodpaster B.H. Skeletal muscle triglyceride: an aspect of regional adiposity and insulin resistance. Diabetes Care 24 (2001) 933-941
28. Phillips D.I., Caddy S., Ilic V., Fielding B.A., Frayn K.N., Borthwick A.C., and Taylor R. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 45 (1996) 947-950
29. Boden G., Lebed B., Schatz M., Homko C., and Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50 (2001) 1612-1617
30. Koyama K., Chen G.D., Lee Y., and Unger R.H. Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am J Physiol 273 pt 1 (1997) E708-E713
31. Sprecher D.L., Massien C., Pearce G., Billin A.N., Perlstein I., Willson T.M., Hassall D.G., Ancellin N., Patterson S.D., Lobe D.C., and Johnson T.G. Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor δ agonist. Arterioscler Thromb Vasc Biol 27 (2007) 359-365
32. Wei Z.L., and Kozikowski A.P. A short and efficient synthesis of the pharmacological research tool GW501516 for the peroxisome proliferator-activated receptor δ. J Org Chem 68 (2003) 9116-9118
33. Sznaidman M.L., Haffner C.D., Maloney P.R., Fivush A., Chao E., Goreham D., Sierra M.L., LeGrumelec C., Xu H.E., Montana V.G., et al. Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ)-synthesis and biological activity. Bioorg Med Chem Lett 13 (2003) 1517-1521
34. von Eckardstein A., Nofer J.R., and Assmann G. High density lipoproteins and arteriosclerosis: role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 21 (2001) 13-27